Harold W Holloway Selected Research

Harold W Holloway Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 10/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 11/2002
6	Stroke (Strokes) 10/2013 - 11/2002
4	Type 2 Diabetes Mellitus (MODY) 10/2013 - 07/2003
4	Neuroblastoma 06/2010 - 11/2005
3	Cognitive Dysfunction 01/2017 - 04/2007
3	Amyloid Plaque 01/2013 - 09/2006
3	Inflammation (Inflammations) 01/2013 - 10/2009
3	Parkinson Disease (Parkinson's Disease) 01/2012 - 01/2009
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 01/2016
2	Brain Concussion (Cerebral Concussion) 01/2016 - 10/2013
2	Neuroinflammatory Diseases 05/2012 - 10/2009
2	Disease Progression 05/2012 - 08/2006
2	Erythema Nodosum 01/2004 - 11/2003
1	Blast Injuries 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012
1	Myasthenia Gravis 07/2010
1	Wounds and Injuries (Trauma) 04/2010
1	Hyperkinesis 03/2010
1	Huntington Disease (Huntington's Disease) 03/2010
1	Parkinsonian Disorders (Parkinsonism) 01/2009
1	Dementia (Dementias) 06/2008
1	Infarction (Infarctions) 03/2007
1	Hemorrhage 03/2007
1	Atrophy 02/2007
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2007
1	Diabetes Mellitus 02/2007
1	Ischemia 01/2007
1	Brain Injuries (Brain Injury) 01/2007
1	Cocaine-Related Disorders (Cocaine Addiction) 07/2005
1	Insulinoma 06/2005
1	Necrosis 11/2004
1	Rheumatoid Arthritis 01/2004
1	Neoplasms (Cancer) 11/2003
1	Communicable Diseases (Infectious Diseases) 11/2003
1	Multiple Myeloma 11/2003

Drug/Important Bio-Agent (IBA)

6	Glucagon-Like Peptide-1 ReceptorIBA 01/2016 - 06/2005
5	Exenatide (Byetta)FDA Link 01/2017 - 02/2007
5	Cholinergic Agents (Cholinergics)IBA 01/2016 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2005
5	Peptides (Polypeptides)IBA 01/2013 - 06/2005
4	phenserineIBA 01/2016 - 01/2007
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 05/2008
4	CytokinesIBA 01/2013 - 01/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 11/2003
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2012 - 07/2003
4	Amyloid beta-PeptidesIBA 01/2010 - 11/2005
2	IncretinsIBA 10/2013 - 06/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2013 - 08/2006
2	PhysostigmineIBA 07/2010 - 02/2005
2	AntioxidantsIBA 04/2010 - 01/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2008 - 11/2005
2	AcetylcholinesteraseIBA 04/2007 - 11/2005
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 02/2007 - 11/2004
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2007 - 10/2002
2	Amyloidogenic ProteinsIBA 09/2006 - 02/2005
2	ButyrylcholinesteraseIBA 11/2005 - 07/2005
2	Thalidomide (Thalomid)FDA Link 01/2004 - 11/2003
1	SynaptophysinIBA 01/2017
1	InterleukinsIBA 01/2013
1	LipopolysaccharidesIBA 05/2012
1	3,6'-dithiothalidomideIBA 05/2012
1	Neostigmine (Neostigmine Bromide)IBA 07/2010
1	PhenylcarbamatesIBA 07/2010
1	Cholinesterases (Cholinesterase)IBA 07/2010
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 07/2010
1	Hormones (Hormone)IBA 06/2010
1	Superoxide Dismutase-1IBA 04/2010
1	Tetrabenazine (Nitoman)FDA Link 03/2010
1	Dopamine (Intropin)FDA LinkGeneric 01/2009
1	Blood Glucose (Blood Sugar)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2009
1	Scopolamine (Hyoscine)FDA Link 04/2007
1	1- (2- (decylthio)ethyl)azacyclopentane- 2- oneIBA 04/2007
1	tartaric acid (tartrate)FDA Link 04/2007
1	triphenyltetrazoliumIBA 03/2007
1	Caspase 3 (Caspase-3)IBA 03/2007
1	Vitamin B 6IBA 02/2007
1	Uric Acid (Urate)IBA 01/2007
1	EnzymesIBA 08/2006
1	VaccinesIBA 08/2006
1	AntibodiesIBA 08/2006
1	ImmunosorbentsIBA 08/2006
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2005
1	helospectin IIBA 06/2005
1	CarbamatesIBA 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 11/2002
1	Neuroprotective AgentsIBA 11/2002
1	CamptothecinIBA 11/2002
1	Nicotine FDA Link 10/2002

Therapy/Procedure

1	Oral Administration 04/2007
1	Therapeutics 08/2006